Boryung Pharmaceutical Co., Ltd

This study tested a new combination pill designed to treat two common conditions at once: high blood pressure and high cholesterol. It involved 156 adults with both conditions and compared the new pill's effectiveness and safety against standard treatments over 8 weeks. The goal …

This study observed nearly 1,840 real-world patients with high cholesterol who were prescribed a single pill containing two medications (atorvastatin and ezetimibe). The goal was to see how well and how safely this combination treatment worked over 24 weeks to lower 'bad' cholest…

This first-in-human study tested a new oral drug called BR101801 in adults with advanced blood cancers that had returned or stopped responding to other treatments. The main goals were to find a safe dose and see how the body processes the drug. Researchers also looked for early s…

This early-stage study tested how the body absorbs and processes a new combination drug called BR1018, intended for high blood pressure and high cholesterol. Researchers gave single doses to 60 healthy volunteers to measure drug levels in the blood and check for safety. The goal …

This study observed how doctors choose chemotherapy treatments for patients with advanced pancreatic cancer that cannot be surgically removed. Researchers followed 799 patients in Korea for one year to see which drug combinations were used, why they were chosen, and how patients …

This study observed over 6,400 surgery patients to see how doctors use a drug called sugammadex, which helps reverse muscle paralysis from anesthesia. Researchers tracked how often the drug was given, how well it worked to restore muscle strength, and what side effects occurred. …